How to raise venture debt for your startup in 2026. Active venture debt lenders, post-Silicon Valley Bank collapse reality.
Venture debt — Silicon Valley Bank (collapsed March 10, 2023, First Citizens Bank acquired March 27, 2023, has been rebuilding as SVB / First Citizens division), First Republic (collapsed May 1, 2023, JPMorgan acquired), Signature Bank (collapsed March 12, 2023, Flagstar / NYCB acquired), plus surviving + expanding lenders (HSBC Innovation Banking / SVB UK acquired for £1 March 2023, Hercules Capital public, TriplePoint Capital public, Runway Growth Finance public, WTI, Trinity Capital public, Horizon Technology Finance public, ORIX Growth Capital, plus expanded activity from JPMorgan, Bank of America, PNC, Comerica, HSBC, Bridge Bank / Western Alliance, Stifel, Pacific Western Bank / Banc of California), and specialty debt (Blackrock Innovation Capital, KeyBank, Barings, Ares, Golub, Runway Growth Finance, Vista Credit Partners, Wellington Management, plus BlackRock, Blue Owl / Owl Rock).
Silicon Valley Bank collapsed March 10, 2023 (second-largest US bank failure in history, $209B assets, largest lender to venture-backed startups with reported ~50% market share of venture debt at time of failure). FDIC seized the bank, First Citizens Bank acquired the deposits + loan book March 27, 2023 and has been operating as SVB / First Citizens division. Signature Bank collapsed March 12, 2023 (Flagstar / NYCB acquired), First Republic collapsed May 1, 2023 (JPMorgan acquired). HSBC acquired SVB UK for £1 on March 13, 2023 and rebranded as HSBC Innovation Banking. The 2023 banking crisis reshuffled the venture debt ecosystem materially — commercial-bank venture debt is more disciplined + risk-selective, specialty BDC + direct lenders (Hercules, TriplePoint, Trinity, Runway Growth, Horizon) picked up significant market share, and pricing widened modestly (interest 10-14% base vs 8-12% pre-2023, warrant coverage 10-25% vs 5-15%).
Commercial banks: SVB / First Citizens (post-March 2023 acquisition, rebuilding as First Citizens' Silicon Valley Bank division), HSBC Innovation Banking (SVB UK acquired for £1 March 2023, rebranded), JPMorgan (Innovation Economy team expanded post-First Republic acquisition May 2023, absorbed First Republic technology + life sciences relationships), Bank of America (Global Commercial Bank technology + life sciences), Comerica (technology + life sciences banking historic), PNC (technology + life sciences), Bridge Bank / Western Alliance (post-SVB collapse expanded), Stifel (technology + venture banking), Pacific Western Bank / Banc of California (technology banking), plus Cadence, Bank of the West / BMO, Umpqua.
Publicly-traded BDCs + specialty lenders: Hercules Capital (HTGC — public BDC, has been most active post-SVB), TriplePoint Capital (TPVG public + TPVC private funds), Runway Growth Finance (RWAY public), Trinity Capital (TRIN public), Horizon Technology Finance (HRZN public), plus WTI (Western Technology Investment private), ORIX Growth Capital, K2 Capital, Espresso Capital, Vista Credit Partners (Vista Equity affiliate), Alter Domus, MidCap Financial, plus Golub, Ares, Barings.
Life sciences specialists: Oxford Finance, Silicon Valley Bank Life Sciences (SVB / First Citizens division), Hercules Life Sciences, Runway Growth Life Sciences, plus specialty life sciences funds (RTW Investments, Deerfield, Perceptive Advisors), K2 HealthVentures.
Alternative + creative structures: Pipe (recurring-revenue financing platform post-restructuring 2023), Capchase (recurring-revenue financing), Founderpath (recurring-revenue financing), Uncapped (recurring-revenue), Wayflyer + Clearco (post-crash e-commerce financing, both materially rationalized), plus revenue-based financing (RBF) providers.
Interest rate: 10-14% base (typically SOFR + 6-10%) for commercial-bank venture debt vs 11-15% for specialty BDC / direct lender debt. Reflects post-2023 rate environment + risk-selective lending.
Term: 36-48 months typical (12-24 month interest-only period, then amortization). Some deals structure balloon or bullet payment at maturity.
Warrant coverage: 5-15% for commercial-bank venture debt, 10-25% for specialty BDC / direct lender debt. Warrant coverage is expressed as % of loan amount at exercise price equal to most recent primary round price or negotiated formula.
Fees: 0.5-1.5% upfront commitment fee, 0.5-1% final payment (back-end) fee, plus legal + expense reimbursement (typically $50K-150K).
Financial covenants: Minimum cash covenant (typically 3-6 months runway), MAC (Material Adverse Change) clause, revenue / ARR covenants for later-stage deals, plus reporting covenants (monthly financials, board deck, cash runway).
Prepayment: Typically no penalty after 12 months, decreasing penalty in first 12 months (2-3% year 1, 1-2% year 2, 0% thereafter typical).
Draw structure: Typically split into 2-3 tranches with milestone conditions (revenue milestones, next equity round completion, product launch).
Raising venture debt without a clear runway extension use case (venture debt is best deployed to bridge to a specific milestone, not general working capital). Not understanding warrant dilution (10% warrant coverage on $10M loan = $1M of warrants at recent primary price, which is meaningful dilution). Ignoring MAC (Material Adverse Change) clause risk — lenders can call the loan on MAC events including material valuation drops, key personnel departures, or major customer losses. Underestimating covenant tripping risk — minimum cash covenants can trip during downturn and force restructuring. Not planning for prepayment penalty in early exit scenarios. Confusing recurring-revenue financing (Pipe, Capchase, Founderpath) with true venture debt — RRF is shorter-term and priced against ARR quality, not company enterprise value. Choosing commercial-bank cheap debt over specialty flexibility when the company has covenant-tripping risk (specialty BDC / direct lender debt is more expensive but more forgiving during downturn).
Investor directory · Fundraising library · Articles A–Z · Company funding database